Lv61
1832 积分 2023-08-20 加入
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
4小时前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
8天前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
8天前
已完结
The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors
1个月前
已完结
Healthcare burden and outcomes of hepatorenal syndrome among cirrhosis‐related hospitalisations in the US
2个月前
已完结
Prognostic significance of mild ascites in patients with cirrhosis
2个月前
已完结
Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy‐proven Japanese non‐alcoholic fatty liver disease patients
2个月前
已完结
Portal inflammation predicts renal dysfunction in patients with nonalcoholic fatty liver disease
2个月前
已完结
Associations of maternal exposure to nonylphenol and bisphenols with precocious puberty in girls: A nested case-control study
3个月前
已完结
Comparative Efficacy of GnRHa Monotherapy vs. Combination Therapy for Central Precocious Puberty: A Systematic Review and Meta-Analysis
3个月前
已完结
皖公网安备34019202002308
